114 related articles for article (PubMed ID: 12113830)
1. Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles.
Boschelli DH; Wang DY; Ye F; Yamashita A; Zhang N; Powell D; Weber J; Boschelli F
Bioorg Med Chem Lett; 2002 Aug; 12(15):2011-4. PubMed ID: 12113830
[TBL] [Abstract][Full Text] [Related]
2. Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Berger D; Dutia M; Powell D; Wissner A; DeMorin F; Raifeld Y; Weber J; Boschelli F
Bioorg Med Chem Lett; 2002 Oct; 12(20):2989-92. PubMed ID: 12270190
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927.
Boschelli DH; Barrios Sosa AC; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2007 Mar; 17(5):1358-61. PubMed ID: 17188862
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles.
Boschelli DH; Wang YD; Ye F; Wu B; Zhang N; Dutia M; Powell DW; Wissner A; Arndt K; Weber JM; Boschelli F
J Med Chem; 2001 Mar; 44(5):822-33. PubMed ID: 11262092
[TBL] [Abstract][Full Text] [Related]
5. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
6. 4-anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitors.
Boschelli DH
Curr Top Med Chem; 2002 Sep; 2(9):1051-63. PubMed ID: 12171571
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity.
Boschelli DH; Ye F; Wu B; Wang YD; Barrios Sosa AC; Yaczko D; Powell D; Golas JM; Lucas J; Boschelli F
Bioorg Med Chem Lett; 2003 Nov; 13(21):3797-800. PubMed ID: 14552782
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles.
Barrios Sosa AC; Boschelli DH; Ye F; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2004 May; 14(9):2155-8. PubMed ID: 15080999
[TBL] [Abstract][Full Text] [Related]
9. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
Boschelli DH; Ye F; Wang YD; Dutia M; Johnson SL; Wu B; Miller K; Powell DW; Yaczko D; Young M; Tischler M; Arndt K; Discafani C; Etienne C; Gibbons J; Grod J; Lucas J; Weber JM; Boschelli F
J Med Chem; 2001 Nov; 44(23):3965-77. PubMed ID: 11689083
[TBL] [Abstract][Full Text] [Related]
10. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
Sun M; Zheng Y; Wei H; Chen J; Ji M
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
[TBL] [Abstract][Full Text] [Related]
11. 7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups.
Wu B; Barrios Sosa AC; Boschelli DH; Boschelli F; Honores EE; Golas JM; Powell DW; Wang YD
Bioorg Med Chem Lett; 2006 Aug; 16(15):3993-7. PubMed ID: 16735116
[TBL] [Abstract][Full Text] [Related]
12. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
[TBL] [Abstract][Full Text] [Related]
13. 8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src kinase inhibitors.
Berger D; Dutia M; Powell D; Wu B; Wissner A; DeMorin F; Weber J; Boschelli F
Bioorg Med Chem Lett; 2002 Oct; 12(19):2761-5. PubMed ID: 12217371
[TBL] [Abstract][Full Text] [Related]
14. 4-Anilino-3-cyanobenzo[g]quinolines as kinase inhibitors.
Zhang N; Wu B; Wissner A; Powell DW; Rabindran SK; Kohler C; Boschelli F
Bioorg Med Chem Lett; 2002 Feb; 12(3):423-5. PubMed ID: 11814812
[TBL] [Abstract][Full Text] [Related]
15. Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase.
Mallon R; Feldberg L; Kim S; Collins K; Wojciechowicz D; Kohler C; Kovacs D; Discafani C; Zhang N; Wu B; Floyd B; Powell D; Berger D
Mol Cancer Ther; 2004 Jun; 3(6):755-62. PubMed ID: 15210862
[TBL] [Abstract][Full Text] [Related]
16. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors.
Wissner A; Berger DM; Boschelli DH; Floyd MB; Greenberger LM; Gruber BC; Johnson BD; Mamuya N; Nilakantan R; Reich MF; Shen R; Tsou HR; Upeslacis E; Wang YF; Wu B; Ye F; Zhang N
J Med Chem; 2000 Aug; 43(17):3244-56. PubMed ID: 10966743
[TBL] [Abstract][Full Text] [Related]
17. MEK (MAPKK) inhibitors. Part 2: structure-activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines.
Zhang N; Wu B; Eudy N; Wang Y; Ye F; Powell D; Wissner A; Feldberg LR; Kim SC; Mallon R; Kovacs ED; Toral-Barza L; Kohler CA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1407-10. PubMed ID: 11378365
[TBL] [Abstract][Full Text] [Related]
18. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
[TBL] [Abstract][Full Text] [Related]
19. The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
Cao X; You QD; Li ZY; Liu XR; Xu D; Guo QL; Shang J; Chern JW; Chen ML
Bioorg Med Chem Lett; 2008 Dec; 18(23):6206-9. PubMed ID: 18930653
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Src kinase activity by 4-anilino-5,10-dihydro-pyrimido[4,5-b]quinolines.
Boschelli DH; Powell D; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2003 Sep; 13(18):2977-80. PubMed ID: 12941315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
